Klein Hersh Adds Industry Expert
April 4, 2025 – Horsham, PA-based Klein Hersh, an executive search firm focused on the life sciences and healthcare industries, has expanded with the addition of Neil Ravitz as vice president, healthcare. “We are thrilled to welcome someone of Neil’s caliber to the growing Klein Hersh team,” said Jason Hersh, CEO of Klein Hersh. “Neil’s deep healthcare industry expertise is a tremendous asset to Klein Hersh, and his strategic insights will help us deliver even greater value to our clients. This marks an exciting next chapter for us.”
Mr. Ravitz brings over 17 years of executive healthcare leadership experience to Klein Hersh, having driven operational and financial success in some of the nation’s leading healthcare institutions. Prior to joining Klein Hersh, he served as SVP of operations for Vytal Assets and as Penn Medicine’s chief administrative officer musculoskeletal and rheumatology service line, representing $450 million in revenue for the health system including 100 physicians across 20 outpatient sites. Also at Penn Medicine, Mr. Ravitz served as COO Department of Orthopaedics, associate executive director for Penn Presbyterian Medical Center, and COO for the office of the CMO. His expertise spans a wide spectrum of healthcare administration including strategy, business development, M&A, clinical roll-ups, scaling healthcare enterprises, and creating operational efficiencies in hospital systems, surgical centers, and med-tech.
Prior to working in the healthcare sector, Mr. Ravitz spent 10+ years in strategy and technology consulting with KPMG and Deloitte. He honed his leadership style and emphasis on core leadership attributes through his graduation from West Point and distinguished military service, including earning numerous awards for his service in Iraq.
In his new role as a key member of Klein Hersh’s growing healthcare practice, Mr. Ravitz will leverage his deep health industry experience and network to drive executive talent strategies for private equity-backed healthcare organizations, transformative healthcare technology and services businesses, and hospital systems seeking to enhance their leadership teams.
“I love the patient-focused mission of healthcare,” Mr. Ravitz said. “It aligns so well with the way that I grew up in the military, in which we were always focused on serving a higher mission. Klein Hersh now presents me with a platform to help companies achieve their missions and meet the needs of patients every day, and I’m honored to be joining an organization that has demonstrated so much success in this space.”
Related: Keys to Succession Planning in Healthcare
“Neil’s role showcases the firm’s commitment to shaping the healthcare industry through the delivery of visionary leaders and signals an expansion in their practice area leadership across pharma, biotech, and healthcare, as well as new verticals and industries to better serve a broader range of clients,” Klein Hersh said.
Life Sciences and Healthcare Focused
Established in 1998, Klein Hersh is an executive search firm that partners with clients to deliver executive leaders for global pharmaceutical, biotech, and healthcare companies as well as operating businesses of PE and VC-backed investments. Noteworthy clients include Akero, Aktis Oncology, Apogee Therapeutics, ArchWell Health, Atlas Venture, BainCapital Life Sciences, Biogen, Capital Rx, ConcertAI, CytoReason, Dispatch, Fairmount, Forbion, Foresite Capital, Frazier Healthcare Partners, Iambic, ITM, Koa Health, LifeMine, LongueVue Capital, Lyric, MacroHealth, McKesson, Moderna, Morningside, Odyssey Therapeutics, Oruka Therapeutics, Pacira Biosciences Inc., Paragon Therapeutics, Posterity Health, Revolution Medicines, TPG, Transformation Capital, Treeline Biosciences, and Unlearn.
Evolving Life Sciences/Healthcare Sector Busier Than Ever for Recruiters
Search consultants continue to say that there is an unprecedented opportunity for visionary healthcare/life sciences leaders to redefine the future of the industry. A shifting economic climate and the rapid pace of innovation have fueled many changes in the healthcare industry through acquisitions, divestitures, and new company formations. The pandemic accelerated the adoption of technologies such as telehealth and remote patient monitoring. At the same time, developments in the life sciences, medicine, pharmaceuticals, and healthcare industries continue to put pressure on businesses to improve their products and services to serve more patients with higher-quality care at a lower cost, according to SPMB.
In 2021, New State Capital Partners, based in Larchmont, NY, took an equity investment stake in Klein Hersh. New State is an entrepreneurial-minded private equity firm that prides itself on a long-term outlook, approaching each potential investment as an opportunity to create lasting and valuable relationships with company founders and especially independent sponsors. The firm has the ability to invest up to $100 million in equity per transaction and seeks to invest in market-leading companies with $8 million to $40 million of EBITDA in the areas of business services, industrials, and consumer.
Related: Leadership Void: Change Agents Sought for Life Sciences Sector
Contributed by Scott A. Scanlon, Editor-in-Chief and Dale M. Zupsansky, Executive Editor – Hunt Scanlon Media
